Hadi Falahatpisheh

A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions

Marc Damelin, Alexander J. Bankovich, Jeffrey Bernstein et al. · Science Translational Medicine · 2017 · 157 citations

Pharmacy, Molecular Pharmaceutics, Oncology +16

Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions

Marc Damelin, Alexander J. Bankovich, Albert Park et al. · Clinical Cancer Research · 2015 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17

Liver Microvascular Injury and Thrombocytopenia of Antibody–Calicheamicin Conjugates in Cynomolgus Monkeys—Mechanism and Monitoring

Magali Guffroy, Hadi Falahatpisheh, Kathleen Biddle et al. · Clinical Cancer Research · 2016 · 67 citations

Medicine, Hematology, Pharmacology +17

PF-06804103, A Site-specific Anti-HER2 Antibody–Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers

Edmund I. Graziani, Matthew Sung, Dangshe Ma et al. · Molecular Cancer Therapeutics · 2020 · 48 citations

Pharmacy, Medicinal Chemistry, Oncology +17

Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade

Andrea T. Hooper, Kimberly Marquette, Chao-Pei Betty Chang et al. · Molecular Cancer Therapeutics · 2022 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17